Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B

Although recombinant adeno-associated virus serotype 8 (AAV8) and serotype 5 (AAV5) vectors have shown efficacy in Phase 1 clinical trials for gene therapy of hemophilia B, it has become increasingly clear that these serotypes are not optimal for transducing primary human hepatocytes. We have previo...

Full description

Saved in:
Bibliographic Details
Published in:Hum Gene Ther
Main Authors: Brown, Harrison C., Doering, Christopher B., Herzog, Roland W., Ling, Chen, Markusic, David M., Spencer, H. Trent, Srivastava, Alok, Srivastava, Arun
Format: Artigo
Language:Inglês
Published: Mary Ann Liebert, Inc., publishers 2020
Subjects:
Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7585622/
https://ncbi.nlm.nih.gov/pubmed/32657150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2020.099
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items